Showing results (61-70 of 322) with videos related to
Sort By:
Pageof 33
Acta Paediatrica (Oslo, Norway : 1992). Supplement|December 24, 1997
Aetiology, morphology and body composition of infants born small for gestational ageA Lapillonne, N Peretti, P S Ho, et al.Gynecologie, Obstetrique & Fertilite|July 12, 2011
[Is it possible to prevent preterm births outside of level-3 maternity wards? Experience of Greater Lyon perinatal network]J Clerc, M Doret, E Decullier, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 4, 2020
Adverse events related to ibuprofen treatment for patent ductus arteriosus in premature neonatesD Ndour, H Bouamari, J Berthiller, et al.Pediatrie|January 1, 1989
[Biosynthetic growth hormone: current therapeutic status and perspectives]P Chatelain, L De Parscau, M NicolinoBiochimica Et Biophysica Acta|May 28, 1985
Semi-empirical conformational analysis of propranolol interacting with dipalmitoylphosphatidylcholineR Brasseur, J M Ruysschaert, P ChatelainBiochemical Pharmacology|April 1, 1984
Conformational analysis of suloctidil and derivatives inserted in lipid layersR Brasseur, J M Ruysschaert, P ChatelainBiochemical Pharmacology|October 7, 1994
Interaction of the calcium antagonist fantofarone with phospholipids: electrostatic effectsP Chatelain, J R Matteazzi, R LaruelProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1986
The molecular weight forms of rat growth hormone secreted in response to growth hormone-releasing factorW B Wehrenberg, P Chatelain, A BairdBiochemical Pharmacology|April 1, 1992
Fluorescent studies on the interaction between a novel Ca2+ antagonist, SR 33557, and membrane lipidsP Chatelain, J R Matteazzi, R LaruelJournal of Pharmaceutical Sciences|May 1, 1994
Binding of fantofarone, a novel Ca2+ antagonist, to serum albumin: a fluorescence studyP Chatelain, J R Matteazzi, R LaruelPageof 33